Business
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
REDWOOD CITY, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its fourth quarter and full
About this update from Coherus Oncology, Inc.
REDWOOD CITY, Calif. , March 05, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences , Inc. (“Coherus,” NASDAQ: CHRS) today announced that its fourth quarter and full year 2023 financial results will be released after market close on Wednesday, March 13, 2024 . Starting at 5:00 pm ET on March 13, 2024 , Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call. Conference Call Information When: Wednesday, March 13, 2024 , starting at 5:00 p.m. Eastern Time To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI41e6b8f8ab024eefafe43493f6fd0cdf Webcast: https://edge.media-server.com/mmc/p/7c7bss7i The press release with the fourth quarter and full year 2023 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call. A live and archived webcast will be available on the “Investors” section of the Coherus website at https://investors.coherus.com/events-presentations . Please dial-in 15 minutes early to ensure a timely connection to the call. Coherus Contact Information Investors: Jami Taylor , Head of Investor Relations for Coherus [email protected] Source: Coherus BioSciences, Inc.
View stock analysis, news, and events for Coherus Oncology, Inc.